NAFDAC Withdraws, Suspends, and Cancels Approval for Multiple Products (FULL LIST)

The National Agency for Food and Drug Administration and Control (NAFDAC) has published the names of products whose registrations have been withdrawn, suspended, or cancelled in Nigeria.

In a statement on its official website on Tuesday, the agency announced that the affected products are no longer authorised for manufacture, importation, exportation, distribution, advertisement, sale, or use within the country.

The list includes Artemether/Lumefantrine 40mg/240mg Tablets, Amaryl M SR Tablets, Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg, Aprovasc 150mg/5mg Tablets, ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets, Betopic Eye Drops, Efavirenz 600mg Tablets, and Flagyl Suspension.

Other products affected are Iliadin Adult 0.05% Metered Nose Spray, Invanz 1g Injections, and Invega (Paliperidone) 3mg Extended Release Tablets.

NAFDAC stated that a product’s certificate of registration is considered withdrawn when the market authorisation holder voluntarily discontinues its use.

Similarly, a certificate may be suspended if the conditions under which it was granted are no longer being met, in which case the agency has the authority to enforce the suspension.

The full list of the 101 products affected by the withdrawal, suspension, or cancellation of registration is: